Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Cigna Corp.
Headquarters: Bloomfield, CT, United States of America
Website: http://www.cigna.com
Year Founded: 1792
Status: Non-biopharma
Biopharma related deals can be found by searching the organization's name in the Deals Module.
BioCentury | Apr 1, 2025
Politics, Policy & Law
FDA layoffs could cripple agency, former FDA commissioners say
Reviews of novel drugs could be disrupted, long-term plans for FDA unclear
BioCentury | Jan 18, 2025
Politics, Policy & Law
FTC calls out PBM price gouging of specialty generic drugs
Report says Big 3 PBMs mark up 22% of specialty generics by more than 1,000%
BioCentury | Jan 16, 2025
Politics, Policy & Law
FDA veterans school Makary
Califf, Gottlieb, McClellan, Woodcock advise the next commissioner to collaborate with staff, push change to keep up with scientific advances
BioCentury | Oct 24, 2024
Politics, Policy & Law
FDA must be protected from politics, say Califf, ex-agency leaders
Celebrating Richard Pazdur’s 25th anniversary, former FDA commissioners say political pressures have intensified
BioCentury | Apr 16, 2024
Politics, Policy & Law
How CMS’s IRA methodology will steer medicine
Choice of comparator will determine if the agency prioritizes innovation or price
BioCentury | Sep 13, 2023
Politics, Policy & Law
IRA list based on politics, pharma veterans say
CMS avoided cancer drugs, prioritized volume over cost to Medicare
BioCentury | Jun 9, 2023
Politics, Policy & Law
Califf, BIO out of sync on accelerated approval, IRA
FDA commissioner endorses Inflation Reduction Act, unlikely to change course on accelerated approval
BioCentury | Apr 10, 2023
Politics, Policy & Law
Abortion decision blow to science-based regulation, legal experts, biopharma leaders say
Concerns raised about Texas ruling’s implications for drug regulation
BioCentury | Feb 23, 2023
Politics, Policy & Law
Republicans criticize IRA drug price-setting, question funding
House, Senate Republicans request details on $3 billion set aside for Inflation Reduction Act implementation
BioCentury | Feb 17, 2023
Regulation
Feb. 16 Quick Takes: FDA approves Chiesi’s Lamzede for ultra-rare lysosomal storage disorder
Plus: August PDUFA for Iveric’s GA therapy and updates from ALS Association, Avilar, Talaris, Senate’s HELP
Items per page:
1 - 10 of 88